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Abstract
Vitamin D has immunomodulatory properties giving it the potential to affect microbial coloni-
zation of the intestinal tract. We investigated whether maternal vitamin D supplemention,
maternal plasma 25-hydroxyvitamin D concentration, or direct supplementation of the infant
influences key bacterial taxa within microbiota of one month old infants. Infant and maternal
vitamin D supplement use was ascertained via questionnaires. Maternal plasma 25-hydro-
xyvitamin D was determined at approximately the 36th week of pregnancy. In 913 one
month old infants in the prospective KOALA Birth Cohort Study, fecal Bifidobacterium spp.,
Escherichia coli, Clostridium difficile, Bacteroides fragilis group, Lactobacillus spp. and total
bacteria were quantified with real-time polymerase chain reaction assays targeting 16S
rRNA gene sequences. The association between vitamin D exposure and prevalence or
abundance of a specific bacterial group or species was analyzed using logistic or linear
regression, respectively. There was a statistically significant negative linear trend between
counts of Bifidobacterium spp. and levels of maternal vitamin D supplementation and mater-
nal 25-hydroxyvitamin D quintiles, respectively. In addition, a positive linear trend between
quintile groups and B. fragilis group counts was observed. Lower counts of C. difficile were
associated with vitamin D supplementation of breast fed infants whose mothers were more
likely to adhere to an alternative lifestyle in terms of, e.g., dietary habits. These data suggest
that vitamin D influences the abundance of several key bacterial taxa within the infant micro-
biota. Given that intestinal microbiotic homeostasis may be an important factor in the pre-
vention of immune mediated diseases and that vitamin D status is a modifiable factor,
further investigation of the impact of postnatal vitamin D supplementation should be con-
ducted in older infants.
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Introduction
The intestinal microbiota plays a decisive role in directing immune development early post-
partum and shaping immune responses throughout life [1]. Studies demonstrate that changes
in microbiota are associated with a variety of immune mediated diseases [2]. The importance
of intestinal bacterial homeostasis in the etiology of diseases emphasizes the need to identify
modifiable factors determining intestinal bacterial composition.
As the intestinal microbiota influences immune function, so can the mucosal immune sys-
tem regulate the composition of the microbiota [3]. The host can control bacterial composition
via the production of antimicrobial peptides (defensins and cathelicidin) along the epithelial
surface [4]. Vitamin D is a known regulator of antimicrobial peptide expression [5] and has
been shown to up-regulate antimicrobial peptide gene expression in a variety of cell types [6–
8], including colonic cells [9]. In addition, a study of sepsis patients demonstrated a positive
association between vitamin D status and plasma cathelicidin concentrations [10]. Vitamin D
also promotes non-inflammatory states by directing immune responses in favor of tolerance
by inhibiting dendritic cell maturation and differentiation [11]. Minimizing intestinal inflam-
mation promotes homeostasis of the microbiota as inflammation is a mechanism whereby
pathogenic bacteria can overcome colonization resistance by resident bacteria [12].
Vitamin D status, therefore, has the potential to influence the intestinal microbiota due to
its promotion of anti-inflammatory responses by the immune system and inhibition of infec-
tions. Given that vitamin D status is a modifiable factor which may influence intestinal micro-
biotic homeostasis, which in turn is indicated to be important in the prevention of immune
mediated diseases, we investigated whether maternal use of multivitamin supplements con-
taining vitamin D, maternal vitamin D status (25 hydroxyvitamin D (25(OH)D), or adminis-
tration of vitamin D supplement to the baby influences the presence and abundance of several
key bacterial taxa of the infant gut microbiota.
Methods
Subjects
The participants were recruited from the prospective KOALA Birth Cohort Study previously
described in detail elsewhere [13]. Briefly, pregnant women were enrolled between the 14th
and 18th week of pregnancy from October 2000 until December 2002. Mothers (n = 2343)
were recruited from an ongoing prospective Dutch cohort study on pregnancy-related pelvic
girdle pain (conventional recruitment group) and through Steiner schools, organic food
shops, and anthroposophic doctors, midwives and magazines (alternative recruitment
group)(n = 491). Most of the women in this latter group were considered to have an alterna-
tive lifestyle, in terms of dietary habits, child rearing practices,vaccination schemes and/or
use of antibiotics. In the alternative recruitment group 73% of the women were vegetarians,
or had organic or macrobiotic dietary habits, compared to 7% in the conventional recruit-
ment group. Comparing the alternative recruitment group to the conventional recruitment
group, the alternative recruitment group had a greater proportion of women with a high edu-
cational level (73% vs. 43%) and who exclusively breast fed in the first 6 months of the child’s
life (56% vs. 20%). Moreover, fewer women in the alternative recruitment group smoked
during pregnancy (1% vs. 8%) and adhered to conventional vaccination schemes (46% vs.
84%), and their infants were less likely to be exposed to environmental tobacco smoke (2%
vs. 14%) [13].
Written informed consent was obtained from the parents and ethical approval was granted
by the Medical Ethics Committee of the University Hospital of Maastricht.
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Beginning in January 2002, consent was also requested to obtain a maternal blood sample
at approximately the 36th week of gestation and an infant fecal sample at one month of age for
microbial analyses. Data regarding possible confounders and vitamin D exposure through sup-
plement use was assessed from questionnaires sent to all parents at 34 weeks of gestation, the
time of fecal sampling and 3 months postpartum, respectively.
Inclusion criteria for the current study included availability of an infant fecal sample and
the accompanying questionnaire data at one month of age, and written informed consent.
Mother—child pairs were excluded for reasons of prematurity (<37 weeks), Down’s Syn-
drome, antibiotic, antimycotic or probiotic use by the infant or antibiotic use by a breast feed-
ing mother prior to fecal sampling. Further exclusions were made for unsuitable infant fecal
samples according to the following criteria: samples weighing less than 1g, or samples collected
before 3 weeks or after 6 weeks of age.
Maternal vitamin D supplement use
Maternal vitamin D intake through use of multivitamin supplements containing vitamin D
was calculated as previously described [14]. Vitamin D dosage in the supplements was esti-
mated according to an overview of vitamin preparations [15] and intake was categorized as
none (0 μg),<10 μg/day or 10 μg/day. Diet and sunlight exposure were not considered as 25
(OH)D concentrations were measured in mothers providing an estimation of exposure based
on all sources and only “yellow fat spreads” were fortified with vitamin D in the Netherlands at
the time of the study.
Infant vitamin D supplement use
Vitamin D supplementation of the infant was categorized as yes or no. Thirty-seven children
received a vitamin A-D supplement and were included in the group of vitamin D supple-
mented children. Sunlight exposure was not considered because one month old babies are typ-
ically covered and not placed in direct sunlight.
Maternal plasma 25(OH)D concentration
Blood samples were immediately centrifuged, transported at 4˚C and stored at -80˚C in a
biobank until further analysis. Plasma concentrations of 25(OH)D were measured with an
ELISA kit from Immuno diagnostic Systems (Boldon, UK) according to the manufacturer’s
instructions.
Fecal sample collection, DNA isolation and microbial analysis
The collection of fecal samples has been described in detail elsewhere [16]. Briefly, parents
placed a sanitary napkin in the diaper to prevent absorption of the feces and sent the sample
(without the addition of preservation media) on the same day to the laboratory by post. Sam-
ples were diluted tenfold in peptone-water (Oxoid CM0009) containing 20% v/v glycerol
(Merck, Darmstadt, Germany) and stored at -20˚C until analyzed. DNA was isolated from the
feces using a method previously described in detail [16] based upon bead-beating followed by
the use of the QIAamp DNA stool mini kit (Qiagen, Hilden, Germany) according to the man-
ufacturer’s instructions. Quantification of Bifidobacterium spp, Escherichia coli, Clostridium
difficile, Bacteroides fragilis group, Lactobacillus spp and total bacteria was achieved with real-
time polymerase chain reaction assays targeting 16S ribosomal ribonucleic acid (rRNA) gene
sequences. The 5’-nuclease technique was used to detect Bifidobacterium spp, E. coli, C. difficile.
and the B. fragilis group. Lactobacillus spp and total bacteria were detected with SYBR Green 1
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(Bio-Rad Laboratories, Hercules, CA). Specifics regarding the primers, probes and PCR condi-
tions have been presented elsewhere [16]. Bacterial counts were determined from the threshold
cycle values by using the constructed standard curves. The outcomes investigated were preva-
lence of colonization by a specific bacterial species or group which was expressed as yes or
no, and counts of bacteria defined as log10 colony forming units (CFU)/g feces of colonized
infants.
Statistical analyses
The association between vitamin D exposure and prevalence or exposure and abundance of
specific groups or species (log10 CFU/g wet weight faeces) only in infants who were colonized
with the bacteria under study was analyzed using logistic or linear regression, respectively.
The potential confounders included in the models can be found in the tables depicting
the results of the analyses. In the analysis regarding supplementation of the infant, both bottle
fed and combination fed (bottle and breast milk) children were excluded because commercial
formulas contain vitamin D and the amount of vitamin D supplementation would vary
depending on the volume of formula consumed. The analyses regarding maternal vitamin D
supplementation and maternal 25(OH)D quintiles were performed on the entire population
because the exposure of interest was prenatal, i.e. occurring before the introduction of either
formula or breast milk. Cases with missing data were excluded when the exposure, outcome or
confounder variable was missing. Due to the study design, we tested for possible interaction
between vitamin D exposure and recruitment group (conventional/alternative). When the p
value for the interaction term was < 0.05, stratification by recruitment group was undertaken
to account for effect modification. The categorical variables, quintiles of maternal 25(OH)D
and amount of maternal vitamin D supplementation, were transformed into interval variables
to conduct the tests for interaction, as well as the tests for linear trend performed with linear
regression. An unpaired t test was conducted to compare the mean maternal 25(OH)D con-
centrations between mothers who used supplements and those who did not. Data analysis was
performed using SPSS 20.0 for Windows (Chicago, IL) and p<0.05 was considered statistically
significant. False disovery rate (FDR) was applied to the ten tests for linear trend to correct for
multiple testing (q = 0.05).
Results
Study population
There were 1176 potentially eligible participants from the KOALA cohort (children with a
fecal sample). For technical reasons, 144 infants were excluded because the fecal sample:
weighed < 1 g (n = 65), was collected before 3 weeks or after 6 weeks of age (n = 25), or the
questionnaire accompanying the fecal sample was not submitted (n = 25). Other reasons for
exclusion from the analysis included premature birth (< 37 weeks) (n = 14), Down’s Syn-
drome (n = 3), antibiotic or antimycotic use by the infant or antibiotic use by a breast feeding
mother prior to fecal sampling (n = 95), lack of information about antimicrobial use (n = 4),
uncertainity concerning antimicrobial use (n = 1) and administration of probiotics to the child
during the first month of life (n = 2), resulting in 913 participants in the study. The analyses
concerning vitamin D supplementation of the breast fed infant included 616 individuals after
omitting infants receiving formula (n = 208), both breast milk and formula (n = 87) and lack
of information regarding feeding (n = 2).
The prevalence of colonization of neonatal fecal samples with the studied bacteria was
98.7% (901/913) for bifidobacteria, 88.7% (807/910) for E. coli, 81.5% (744/913) for B. fragilis
group, 25.1% (229/913) for C. difficile and 32% (292/913) for lactobacilli.
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Table 1 depicts the numbers of participants according to: vitamin D supplement adminis-
tration to the infant, maternal use of multivitamin supplements containing vitamin D, and
maternal 25(OH)D quintiles and other characteristics. The characteristics of the breast fed
children were fairly similar between the children receiving vitamin D supplementation and
those who did not, except that mothers who were recruited in the conventional recruitment
group were more likely to give their child vitamin D supplementation than those in the alter-
native recruitment group. There was also a minor difference in that parents with more chil-
dren tended not to supplement their infant with vitamin D. In terms of use of multivitamin
supplements containing vitamin D, by the mother, those in the conventional group were more
represented in the none and highest categories of supplementation with approximately equal
representation of recruitment groups occuring in the< 10 μg category. Finally, there was an
expected difference among the quintiles in terms of season of blood sampling in that the higher
quintiles included a lower percentage of mothers giving blood during the winter season and a
higher percentage in the summer.
Maternal 25(OH)D and use of multivitamin supplements containing
vitamin D
Maternal 25(OH)D concentrations of the entire group ranged from 7.7 to 126.3 nmol/L with a
mean of 44.3, SD 18.3 nmol/L. The relationship between maternal 25(OH)D and maternal use
of multivitamin supplements containing vitamin D is shown in Table 2. During seasons of
both high and low cutaneous production of vitamin D, the mean maternal plasma 25(OH)D
concentrations were significantly greater in mothers who used vitamin D containing supple-
ments compared to those who did not. Use of multivitamin supplements containing vitamin
D and maternal obesity were associated with maternal 25(OH)D level during both low and
high seasons, while recruitment group was significantly associated with 25(OH)D concentra-
tion only during the high season.
Maternal vitamin D intake through use of multivitamin supplements
containing vitamin D
Maternal use of multivitamin supplements containing vitamin D was not associated with the
prevalence of any of the bacteria in both the unadjusted and adjusted analyses (data not shown).
There was a statistically significant negative linear trend between categories of maternal vitamin
D supplementation and counts of Bifidobacterium spp. and C. difficile, respectively (Table 3)(for
a visualisation of the data in univariable boxplots see also S1 Fig). The trend for bifidobacteria
remained statistically significant following correction for multiple testing using the FDR.
Maternal plasma 25-hydroxyvitamin D quintiles
The likelihood of colonization with B. fragilis was increased in the second 25(OH)D quintile
compared to the first (OR = 2.30; 95% CI: 1.29, 4.13 and adjOR = 2.17; 95% CI 1.16, 4.05). A
negative linear trend between quintile groups and bifidobacteria counts and a positive linear
trend between quintile groups and B. fragilis group counts were observed (Table 4) (for a visu-
alisation of the data in univariable boxplots see also S2 Fig). Both trends remained statistically
significant following correction for multiple testing using the FDR.
Vitamin D supplementation of the infant
There was no influence of vitamin D supplementation of the infant during the first month of
life on the prevalence of any of the bacterial species or groups (data not shown). Table 5 shows
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the association between vitamin D supplementation of the infant in the first month of life and
the log10 CFUs of the different bacteria in children colonized with the respective bacterial
group or species (for a visualisation of the data in univariable boxplots see also S3 Fig).
Effect modification by recruitment group (alternative vs conventional) was observed for
counts of B. fragilis group (p-value for interaction p = 0.036) and C. difficile (p-value for inter-
action p = 0.032). Following stratification by recruitment group, no effect was observed for B.
fragilis in the conventional (adjB = 0.34; 95% CI: -0.02, 0.71) or alternative (B = -0.18; 95% CI:
-0.50, 0.15) groups. Lower counts of C. difficile were associated with vitamin D supplementa-
tion in the alternative group (B = -1.45 log10 CFU/g feces; 95% CI: -2.63, -0.28) with no associ-
ation found in the conventional group (B = 0.49; 95% CI: -0.71, 1.69).
Discussion
The objective of this study was to investigate the potential of vitamin D to influence the pres-
ence and or abundance of several key bacterial taxa within the infant intestinal microbiota. We
theorized that vitamin D could impact intestinal colonization due to its immunomodulatory
effects [17,18]; namely, through its inhibition of intestinal infections via stimulated antimicro-
bial peptide production and promotion of anti-inflammatory responses by the immune sys-
tem. The abundance of several bacterial taxa in infant fecal samples at one month after birth
was shown to be associated with pre- or postnatal vitamin D exposure, supporting the postula-
tion that vitamin D can influence the composition of the intestinal microbiota.
The intestinal mucosa is faced with the constant task of differentiating between commensal
and pathogenic microbiota. Acceptance of commensal organisms is characterized by tolerance
which is achieved by regulating innate and adaptive immune responses to dampen inflammation,
Table 2. Mean maternal 25(OH)D concentration according to season of blood sampling and use of
multivitamin supplements containing vitamin D.
Blood sampling in high season
of cutaneous vitamin D
production
Blood sampling in low season
of cutaneous vitamin D
production
Maternal use of multivitamin
supplement containing vitamin D
Maternal Plasma 25(OH)D
nmol/L
Maternal Plasma 25(OH)D
nmol/L
No (mean (SD)) 45.2 (17.0) 30.1 (13.5)
Yes (mean (SD)) 53.3 (17.8) 40.9 (16.1)
p value& p = 0.000 p = 0.000
Model # Beta (95% CI) Beta (95% CI)
Constant 52.7 (47.7, 57.7) 34.6 (29.5, 39.7)
Maternal use of multivitamin
supplement containing vitamin D
(yes vs. no)
7.8 (4.7, 10.9) 10.7 (7.6, 13.8)
Pre-pregnancy overweight vs. not
overweight
-9.8 (-14.5, -5.0) -5.4 (-10.8, -0.05)
Alternative vs. Conventional
recruitment group
-4.6 (-7.8, -1.4) -3.1 (-6.4, 0.3)
High season = April–October, Low Season = November–March; Overweight = Body mass index > 90th
percentile;
& unpaired t-test;
# regression coefficients (Beta) from multivariable linear regression analysis indicate the difference in
maternal plasma 25(OH)D in nmol/L between the group of mothers taking multivitamin supplement
containing vitamin D and those who did not while controlling for the other factors in the model
https://doi.org/10.1371/journal.pone.0188011.t002
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whereas the latter is directed toward elimination of pathogens with accompanying tissue damage
[19].
Vitamin D modulates innate immunity by regulating one of its main actors, antimicrobial
peptides (AMP), which have a variety of functions not only including microbiocidal activity
and chemotaxis of inflammatory immune cells [4]. It has been demonstrated that the level of
expression of AMP can influence the relative composition of the intestinal microbiota in a
transgenic mouse model for human α-defensin 5 (HD5) [20] and in mice deficient for murine
α-defensins [21]. The function of vitamin D in regulating AMP production, therefore, suggests
that vitamin D status could influence the composition of the intestinal microbiota.
Active vitamin D influences tolerance by inhibiting dendritic cell maturation and differen-
tiation. This leads to increased secretion of interleukin 10 (IL-10), favoring the induction of
regulatory T cells and their production of IL-10, over inflammatory T cell formation [11]. This
type of regulated immune response mirrors the tactic employed by some commensal bacterial
species in order to avoid elimination [12,22]. Minimizing intestinal inflammation promotes
homeostasis of the microbiota as inflammation can serve as a mechanism whereby pathogenic
bacteria can overcome colonization resistance by resident bacteria [12]. This is supported by a
study [23] demonstrating that an avirulent strain of Salmonella, incapable of inciting inflam-
mation, could only colonize the murine intestine in induced- colitis models or IL-10 knock-
out mice. A state of vitamin D deficiency resulting in a pro-inflammatory state and increased
Table 3. Association between maternal use of multivitamin supplements containing vitamin D and log10 colony forming units of bacterial species
or groups in infants colonized with the respective bacteria.
Maternal use of multivitamin supplements containing vitamin D
Maternal multivitamin supplementation containing vitamin D Bacteria &n Unadjusted B (95% CI) #Adjusted B (95% CI)
none Bifidobacterium spp. 346 0 (reference) 0 (reference)
< 10 μg 143 -0.20 (-0.38, -0.02) -0.13 (-0.31, 0.04)
 10 μg 412 -0.15 (-0.28, -0.02) -0.16 (-0.29, -0.04)
P for linear trend p = 0.012*
none Escherichia coli 306 0 (reference) 0 (reference)
< 10 μg 127 -0.11 (-0.38, 0.15) -0.02 (-0.26, 0.23)
 10 μg 374 -0.10 (-0.30, 0.09) -0.09 (-0.27, 0.09)
P for linear trend p = 0.329
none Bacteroides fragilis group 281 0 (reference) 0 (reference)
< 10 μg 117 0.11 (-0.18, 0.40) 0.18 (-0.06, 0.41)
 10 μg 346 -0.02 (-0.23, 0.20) 0.01 (-0.17, 0.18)
P for linear trend p = 0.997
none Clostridium difficile 84 0 (reference) 0 (reference)
< 10 μg 35 -0.46 (-1.25, 0.33) -0.68 (-1.45, 0.08)
 10 μg 110 -0.46 (-1.03, 0.10) -0.59 (-1.14, -0.04)
P for linear trend p = 0.038
none Lactobacillus spp. 116 0 (reference) 0 (reference)
< 10 μg 48 0.02 (-0.21, 0.24) 0.01 (-0.20, 0.22)
 10 μg 128 -0.01 (-0.17, 0.16) 0.03 (-0.12, 0.19)
P for linear trend p = 0.684
& number of infants colonized;
# adjusted for: place and mode of delivery, number of siblings, recruitment group, total bacterial counts, sex, vaginitis during the last month of pregnancy
and mode of infant nutrition;
* remained statistically significant after correction with FDR (q < 0.05)
https://doi.org/10.1371/journal.pone.0188011.t003
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susceptibility to intestinal infections, therefore, may lead to altered microbial colonization
known as dysbiosis or disturbance of the balance between beneficial commensal and patho-
genic species [24].
In summary, the role of vitamin D is most likely to regulate the immune response to main-
tain immune homeostasis [25] by balancing activation of tolerance and the innate immune
system. Although vitamin D promotes immune tolerance, adequate adaptive immune
response, as measured by IgG production in response to infection or vaccination, has been
observed in patients with relatively high serum 25(OH)D levels, suggesting that vitamin D
maintains immune stability by preventing excessive immune responses in either direction
[26].
Table 4. Association between maternal 25(OH)D levels during pregnancy and log10 colony forming units of bacterial species or groups in infants
colonized with the respective bacteria.
Maternal 25(OH)D Bacteria &n Unadjusted B (95% CI) #Adjusted B (95% CI)
Quintile 1 Bifidobacterium spp. 176 0 (reference) 0 (reference)
Quintile 2 178 0.06 (-0.12, 0.25) -0.02 (-0.20, 0.16)
Quintile 3 175 0.07 (-0.11, 0.26) -0.01 (-0.20, 0.17)
Quintile 4 175 -0.09 (-0.27, 0.10) -0.14 (-0.33, 0.06)
Quintile 5 176 -0.19 (-0.38, -0.01) -0.25 (-0.46, -0.05)
p for linear trend p = 0.010*
Quintile 1 Escherichia coli 155 0 (reference) 0 (reference)
Quintile 2 160 -0.06 (-0.34, 0.22) -0.09 (-0.35, 0.17)
Quintile 3 160 0.04 (-0.24, 0.32) -0.04 (-0.31, 0.22)
Quintile 4 156 -0.06 (-0.34, 0.22) -0.06 (-0.33, 0.22)
Quintile 5 159 -0.04 (-0.32, 0.24) -0.09 (-0.38, 0.19)
p for linear trend p = 0.655
Quintile 1 Bacteroides fragilis group 138 0 (reference) 0 (reference)
Quintile 2 159 0.15 (-0.15, 0.45) 0.06 (-0.19, 0.30)
Quintile 3 150 0.42 (0.12, 0.72) 0.30 (0.05, 0.55)
Quintile 4 139 0.29 (-0.02, 0.60) 0.24 (-0.02, 0.50)
Quintile 5 142 0.09 (-0.22, 0.39) 0.28 (0.01, 0.55)
P for linear trend p = 0.014*
Quintile 1 Clostridium difficile 46 0 (reference) 0 (reference)
Quintile 2 42 -0.40 (-1.22, 0.43) -0.34 (-1.16, 0.48)
Quintile 3 55 -0.43 (-1.20, 0.34) -0.40 (-1.19, 0.40)
Quintile 4 42 -0.04 (-0.86, 0.79) 0.19 (-0.66, 1.04)
Quintile 5 41 -0.61 (-1.45, 0.22) -0.30 (-1.18. 0.58)
P for linear trend p = 0.949
Quintile 1 Lactobacillus spp. 60 0 (reference) 0 (reference)
Quintile 2 68 0.01 (-0.21, 0.24) 0.01 (-0.21, 0.22)
Quintile 3 49 -0.11 (-0.35, 0.14) -0.18 (-0.41, 0.06)
Quintile 4 51 0.02 (-0.22, 0.26) 0.04 (-0.20, 0.28)
Quintile 5 58 -0.06 (-0.30, 0.17) 0.08 (-0.17, 0.33)
P for linear trend p = 0.459
& number of children colonized;
# Adjusted for: place and mode of delivery, number of siblings, recruitment group, total bacterial counts, sex, vaginitis during the last month of pregnancy,
mode of infant nutrition and season of blood sampling; Quintile 5 is the highest quintile;
* remained statistically significant after correction with FDR (q < 0.05)
https://doi.org/10.1371/journal.pone.0188011.t004
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Investigations studying the effect of vitamin D status on the composition of the intestinal
microbiota are few; one study was performed in vitamin D deficient mice and two investiga-
tions in humans examined the role of vitamin D as secondary questions. Compatible with our
present study, the results of these three investigations suggest that vitamin D may play a role in
shaping the intestinal microbiota. In a mouse model of induced colitis, vitamin D deficient
mice were shown to have decreased colonic antimicrobial activity (angiogenin-4 protein) and
higher levels of 16S rDNA in colonic tissue (bacterial infiltration) compared to vitamin D suffi-
cient mice [27]. In humans, a study investigating variation in diet and microbial composition
of the intestinal tract between 52 African Americans and 46 Caucasian Americans found dis-
cordant vitamin D supplementation practices and differences between the counts of Bacteroi-
detes in the fecal samples between the two groups [28]. In a cross sectional analysis of 98 adults
examining enterotype partitioning in relation to nutrient consumption (food frequency ques-
tionnaire), vitamin D supplement use and vitamin D from dairy sources were found to be
associated with enterotypes. This finding, however, was no longer statistically significant fol-
lowing correction for multiple testing using the FDR [29].
Here we report on an association between prenatal vitamin D exposure and the abundance
of several key bacterial taxa in the infant intestinal microbiota. The influence of direct vitamin
D supplementation of the child differed between the two recruitment groups suggesting that
lifestyle factors are modulating the association between vitamin D and the intestinal bacterial
taxa. These two recruitment groups differ with respect to dietary habits, e.g., those in the alter-
native group tend to follow an organic or biodynamically produced diet with a higher intake
of fermented legume and cereal products like tofu and seitan, and restricted use of antibiotics
and vaccinations [13]. The latter differences, however, do not pertain to this study as antibiotic
use was a ground for exclusion and vaccinations have not yet begun in one month olds. Mater-
nal diet or other unidentified factors, e.g., health issues leading to the choice of an alternative
lifestyle, could be modifying the effect of vitamin D on the intestinal bacteria and, therefore,
recruitment group was adjusted for in the multivariable analyses.
A strength of our study is that we investigated the influence of both maternal supplementa-
tion and that of the child. For the latter, we were able to adjust for the maternal 25(OH)D con-
centration during the 36th week of pregnancy. This is important because the 25(OH)D status
Table 5. Association between vitamin D supplementation of the infant and log10 colony forming units/g feces of bacterial species or groups in
breast fed infants (n = 616) colonized with the respective bacteria.
Vitamin D Supplement Use of Breast Feeding Infants
Vitamin D supplementation Bacteria &n Unadjusted B (95% CI) #Adjusted B (95% CI)
No use Bifidobacterium spp. 164 0 (reference) 0 (reference)
Use 435 -0.10 (-0.26, 0.05) -0.12 (-0.28, 0.04)
No use Escherichia coli 134 0 (reference) 0 (reference)
Use 385 0.02 (-0.24, 0.27) -0.02 (-0.27, 0.24)
No use Bacteroides fragilis group 130 0 (reference) 0 (reference)
Use 348 0.05 (-0.21, 0.32) -0.02 (-0.26, 0.21)
No use Clostridium difficile 35 0 (reference) 0 (reference)
Use 95 -0.48 (-1.19, 0.23) -0.40 (-1.15, 0.34)
No use Lactobacillus spp. 45 0 (reference) 0 (reference)
Use 132 -0.10 (-0.31, 0.11) -0.15 (-0.37, 0.07)
& number of children colonized;
# adjusted for: place and mode of delivery, number of siblings, recruitment group, total bacterial counts, sex, vaginitis during the last month of pregnancy,
and quintile of maternal 25(OH)D level.
https://doi.org/10.1371/journal.pone.0188011.t005
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of the one month old infant is still highly influenced by the maternal 25(OH)D concentration
due to the approximately three week half life of circulating 25(OH)D [30]. In a future study, it
would be preferable to investigate the impact of postnatal vitamin D supplementation in older
infants whose 25(OH)D concentrations have reached a steady state.
Another strength of this analysis is that we were able to adjust for factors known to influ-
ence the composition of the microbiota of the infant, such as location and mode of delivery,
type of infant feeding and number of older siblings and we excluded for two other determi-
nants of intestinal microbiota, prematurity and exposure to antimicrobials [16].
A limitation of this study concerns the lower numbers of infants in the reference groups for
C. difficile (n = 35) and lactobacillus spp. (n = 45) for the analyses involving vitamin D supple-
mentation of the child or maternal vitamin D quintile. The number of infants not adminis-
tered vitamin D supplementation was low because it is standard practice to supplement breast
fed children with vitamin D, and the lower prevalence of colonization with these bacteria also
contributed to this limitation.
Although we adjusted for the type of infant feeding in the maternal analyses, residual con-
founding may still be present because the infants with combined feeding were considered as
an homogenous group. This group could theoretically represent infants ranging from those
who were fed formula once a day to those who were breast fed only once a day.
Another limitation of our study is that no preservation or stabilization medium was added
to the fecal samples during the transport to the laboratory. Theoretically this could have intro-
duced bias in the bacterial composition due to the overgrowth of some bacteria or the DNA
degradation of others. However, several studies have demonstrated a rather stable microbiota
profile of fecal samples during storage at room temperature for up to 72 hours or more indicat-
ing that such bias might be limited [31–33].
Finally, the study is limited by the use of a single fecal sample which only represents a snap-
shot of the rapidly evolving microbiota composition. Inclusion of consecutive sampling would
have been preferable.
To our knowledge, this is the first report of a large scale observational study indicating that
prenatal vitamin D exposure, as measured either by maternal use of multivitamin supplements
containing vitamin D, or 25(OH)D quintiles, influences several important bacterial taxa within
the infant gut.
Confirmation of these findings is necessary because the identification of modifiable factors
which shape the microbial population is important due to the immunomodulatory functions
of the intestinal microbiota, which bestow it with the potential to significantly influence the
development of disease or maintenance of health. The influence of postnatal vitamin D supple-
mentation merits to be analyzed in a larger group of older infants and with extensive microbial
profiling approach.
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